Company intelligence / Profile preview

CEBINA

Vienna, Vienna, Austriacebina.eu ↗

Ownership: Private
Development stage: Other

Overview

CEBINA has enabled several clinical-stage programs through its incubator model. Notably, Eveliqure’s ShigETEC vaccine completed Phase 1 trials for diarrheal disease prevention. The repurposed antihistamine azelastine nasal spray demonstrated antiviral activity against SARS-CoV‑2 in a Phase 2 proof-of-concept study with ongoing Phase 2/3 studies. CALYXHA is advancing small molecule anti-inflammatory drugs in preclinical development

Therapeutic areas: ImmunologyNeurologyInfectious Diseases
Modalities: Small moleculeVaccineProtein (for in-house and spin-out programs)
Industry: Biotech

Drug pipeline

1 asset

azelastine

Phase 2

Indications: COVID-19

Partnerships

Charles River Laboratories – strategic collaboration on neuroscience therapeutics via DanubeNeuro programURSAPHARM Arzneimittel GmbH – partnership to develop azelastine nasal spray as an anti-COVID remedyUniversity of Vienna – academic collaboration with Prof. Robert Konrat on computational drug repurposing

Beyond the preview

Go deeper on CEBINA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CEBINA.

Explore the full profile